tradingkey.logo
tradingkey.logo
Search

Relay Therapeutics Inc

RLAY
Add to Watchlist
18.840USD
-0.350-1.82%
Close 09-18 16:00ET
4.12BMarket Cap
LossP/E TTM

RLAY Financials

See Relay Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Key Financial Ratios

Market Cap
4.12B
Dividend TTM
0.00
P/E TTM
-12.07
EPS TTM
-1.56
Revenue
15.36M
Net Profit
-337.71M
ROE
-40.01%
ROA
-36.39%

Relay Therapeutics Inc Earnings Date

Latest Release
Aug 6, 2026
EPS / Forecast
-0.41/-0.39
Revenue / Forecast
350.00K/872.73K

Financial Statement Highlights

Quarterly
Quarterly+Annual
Quarterly
Annual
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
Financial Indicators
EPS
-0.43%-0.41
10.51%-0.41
30.24%-0.32
31.54%-0.43
40.81%-0.41
26.79%-0.46
32.21%-0.45
-16.83%-0.63
14.24%-0.69
19.92%-0.62
-20.03%-0.67
---0.54
---0.81
---0.78
---0.56
---2.04
----
----
----
----
Revenue
-48.30%350.00K
-60.93%3.00M
--7.00M
--0.00
--677.00K
-23.26%7.68M
--0.00
-100.00%0.00
-100.00%0.00
4327.88%10.01M
-100.00%0.00
7226.16%25.20M
-67.40%119.00K
-46.06%226.00K
-55.38%253.00K
-48.35%344.00K
-56.75%365.00K
-55.99%419.00K
-99.31%567.00K
--666.00K
Net Profit
-18.94%-83.71M
4.90%-73.29M
27.78%-54.89M
15.84%-74.15M
23.68%-70.38M
5.31%-77.06M
8.97%-76.00M
-34.03%-88.11M
6.39%-92.21M
13.64%-81.39M
-23.69%-83.50M
21.91%-65.73M
-28.28%-98.50M
-51.89%-94.24M
-0.07%-67.50M
-38.37%-84.17M
60.30%-76.79M
-47.08%-62.05M
52.67%-67.46M
-68.62%-60.83M
Net Margin
-130.07%-23916.29%
-143.43%-2443.03%
---784.14%
----
---10395.13%
-23.40%-1003.58%
----
----
----
98.05%-813.30%
----
---260.83%
---82777.31%
---41698.67%
---26681.03%
---19770.04%
----
----
----
----
Gross Margin
0.00%100.00%
0.00%100.00%
--100.00%
----
--100.00%
0.00%100.00%
----
----
----
0.00%100.00%
----
--100.00%
--100.00%
--100.00%
--100.00%
--100.00%
----
----
----
----
Debt to assets ratio
----
----
----
----
----
----
----
----
----
--0.00%
--0.00%
--0.00%
--0.00%
--0.00%
--0.00%
--0.00%
----
----
----
----
Revenue
-48.30%350.00K
-60.93%3.00M
--7.00M
--0.00
--677.00K
-23.26%7.68M
--0.00
-100.00%0.00
-100.00%0.00
4327.88%10.01M
-100.00%0.00
7226.16%25.20M
-67.40%119.00K
-46.06%226.00K
-55.38%253.00K
-48.35%344.00K
-56.75%365.00K
-55.99%419.00K
-99.31%567.00K
--666.00K
Operating profit
-18.19%-90.82M
7.40%-78.59M
28.65%-60.63M
16.58%-80.39M
31.47%-76.85M
7.95%-84.87M
9.85%-84.98M
-28.88%-96.37M
-3.63%-112.13M
9.77%-92.19M
-13.03%-94.26M
9.50%-74.78M
-39.42%-108.20M
-51.79%-102.18M
-24.68%-83.39M
-40.07%-82.63M
-32.16%-77.61M
-58.75%-67.32M
-291.17%-66.89M
-61.14%-58.99M
Net Profit
-18.94%-83.71M
4.90%-73.29M
27.78%-54.89M
15.84%-74.15M
23.68%-70.38M
5.31%-77.06M
8.97%-76.00M
-34.03%-88.11M
6.39%-92.21M
13.64%-81.39M
-23.69%-83.50M
21.91%-65.73M
-28.28%-98.50M
-51.89%-94.24M
-0.07%-67.50M
-38.37%-84.17M
60.30%-76.79M
-47.08%-62.05M
52.67%-67.46M
-68.62%-60.83M
Current assets
36.40%928.08M
-10.98%658.46M
-28.54%578.28M
-27.87%624.01M
-3.39%680.39M
-3.95%739.66M
5.08%809.20M
4.01%865.13M
-20.36%704.27M
-19.65%770.10M
-24.46%770.10M
-23.50%831.80M
3.34%884.35M
4.65%958.39M
4.43%1.02B
70.09%1.09B
25.62%855.79M
23.35%915.79M
26.77%976.24M
-11.44%639.26M
Total current liabilities
56.20%50.80M
-19.70%29.75M
-49.58%25.58M
-30.58%32.60M
-27.79%32.52M
-0.25%37.05M
67.59%50.73M
-7.45%46.97M
-37.07%45.04M
-47.29%37.14M
-52.49%30.27M
-28.95%50.75M
63.04%71.58M
69.03%70.47M
161.95%63.71M
150.47%71.43M
72.94%43.90M
159.22%41.69M
78.41%24.32M
82.03%28.52M
Total assets
32.74%967.46M
-12.48%699.61M
-28.69%621.33M
-27.97%670.00M
-5.66%728.84M
-5.00%799.36M
3.24%871.30M
2.55%930.12M
-19.69%772.55M
-18.90%841.44M
-23.26%843.98M
-22.40%906.96M
8.16%962.02M
9.23%1.04B
9.06%1.10B
74.02%1.17B
24.50%889.42M
23.15%949.88M
26.08%1.01B
-10.65%671.62M
Total liabilities
22.58%77.45M
-26.64%57.43M
-41.96%54.27M
-31.74%62.29M
-30.42%63.18M
-18.18%78.28M
1.66%93.50M
-29.03%91.25M
-40.22%90.81M
-37.93%95.68M
-38.50%91.98M
-23.89%128.59M
38.36%151.90M
42.85%154.15M
35.18%149.55M
68.06%168.95M
14.51%109.78M
179.84%107.91M
202.81%110.64M
163.46%100.53M
Total equity
33.70%890.01M
-10.94%642.18M
-27.09%567.06M
-27.56%607.71M
-2.36%665.66M
-3.31%721.08M
3.43%777.79M
7.77%838.86M
-15.85%681.74M
-15.58%745.76M
-20.86%752.00M
-22.14%778.37M
3.91%810.12M
4.92%883.41M
5.84%950.22M
75.06%999.77M
26.05%779.64M
14.90%841.97M
17.62%897.81M
-19.96%571.09M
Net operating income
2.08%-54.11M
30.18%-51.11M
22.47%-44.87M
17.27%-62.12M
16.06%-55.26M
-45.48%-73.21M
35.12%-57.87M
0.42%-75.08M
4.03%-65.83M
25.04%-50.32M
-56.25%-89.19M
-13.99%-75.40M
-20.16%-68.60M
-36.52%-67.13M
-43.75%-57.08M
-24.34%-66.14M
-102.89%-57.09M
-205.43%-49.17M
-12.57%-39.71M
-121.30%-53.20M
Net investment
-569.79%-353.03M
-22.52%32.90M
22.29%35.46M
131.49%39.73M
64.97%75.15M
303.24%42.47M
-51.41%29.00M
-276.78%-126.16M
-11.17%45.55M
-86.02%10.53M
140.61%59.68M
162.50%71.36M
18.18%51.28M
167.01%75.31M
49.81%-146.94M
30.79%27.19M
66.44%43.39M
51.89%-112.38M
-283.07%-292.75M
3.56%20.79M
Net financing
49476.57%323.74M
--138.78M
16.75%934.00K
-99.99%17.00K
-57.65%653.00K
-100.00%0.00
-96.35%800.00K
2214.33%218.89M
-25.87%1.54M
3671.94%48.92M
1779.76%21.92M
-96.69%9.46M
4.21%2.08M
46.89%1.30M
-99.70%1.17M
31592.35%285.87M
78.06%2.00M
-57.03%883.00K
685635.71%384.01M
-99.79%902.00K

Revenue

By Business

Period:
No Data

By Region

Period:
No Data

FAQs

What is the total revenue of Relay Therapeutics Inc?

According to Relay Therapeutics Inc's FY2025 earnings report, its total revenue reached 15.36M, with a year-on-year change of 10.01M.

What are the current assets of Relay Therapeutics Inc?

According to Relay Therapeutics Inc's FY2025 earnings report, its current assets were 578.28M, with a year-on-year change of -28.54.

What are the total assets of Relay Therapeutics Inc?

According to Relay Therapeutics Inc's FY2025 earnings report, its total assets of Relay Therapeutics Inc were 621.33M, with a year-on-year change of -28.69.

What are the total liabilities of Relay Therapeutics Inc?

According to Relay Therapeutics Inc's FY2025 earnings report, its total liabilities of Relay Therapeutics Inc were 54.27M, with a year-on-year change of -41.96.

What is the total equity of Relay Therapeutics Inc?

According to Relay Therapeutics Inc's FY2025 earnings report, its total equity of Relay Therapeutics Inc was 567.06M, with a year-on-year change of -27.09.

What is the net operating income of Relay Therapeutics Inc?

According to Relay Therapeutics Inc's FY2025 earnings report, its net operating income of Relay Therapeutics Inc was -302.74M, with a year-on-year change of 21.50.

What is the net investment of Relay Therapeutics Inc?

According to Relay Therapeutics Inc's FY2025 earnings report, its net investment of Relay Therapeutics Inc was 192.80M, with a year-on-year change of 569.29.

What is the net financing of Relay Therapeutics Inc?

According to Relay Therapeutics Inc's FY2025 earnings report, its net financing of Relay Therapeutics Inc was 1.60M, with a year-on-year change of -99.41.

What is the Earnings Per Share (EPS) of Relay Therapeutics Inc?

According to Relay Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -1.61, with a year-on-year change of 31.83.

What is the net income of Relay Therapeutics Inc?

According to Relay Therapeutics Inc's FY2025 earnings report, its net income was -276.48M, with a year-on-year change of 18.13.

What is the net margin of Relay Therapeutics Inc?

According to Relay Therapeutics Inc's FY2025 earnings report, its net profit margin was -1800.58, with a year-on-year change of 46.65.

What is the Return on Equity (ROE) of Relay Therapeutics Inc?

According to Relay Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -41.12, with a year-on-year change of 6.87.

What is the Return on Assets (ROA) of Relay Therapeutics Inc?

According to Relay Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -37.05, with a year-on-year change of 5.92.

What is the operating profit of Relay Therapeutics Inc?

According to Relay Therapeutics Inc's FY2025 earnings report, its operating profit was -302.74M, with a year-on-year change of 21.50.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.